Achieve Life Sciences Inc

CEO Andrew Goldberg’s massive RSU and option purchases at Achieve Life Sciences signal insider confidence in its nicotine‑addiction and obesity drug pipeline, boosting investor optimism.

Insider buying surge at Achieve Life Sciences shows execs betting on growth; CFO, CEO, and COO each buy options, hinting at a near‑term rally.

Achieve Life Sciences’ top execs buy 180k stock options—signaling confidence and a 3‑year vest plan that could boost share value and support future growth.